High-precision measurement of hydrogen bond lengths in proteins by nuclear magnetic resonance methods

Proteins: Structure, Function and Genetics

Volumn 35, Issue 3, 1999, Pages 275-282

  Harris, Thomas K ^a   Mildvan, Albert S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemical shift; Chymotrypsin; Chymotrypsinogen; Fractionation factor; Ketosteroid isomerase; Serine protease; Subtilisin; Triosephosphate isomerase

Indexed keywords

ACCURACY; HYDROGEN BOND; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

HYDROGEN BONDING; MAGNETIC RESONANCE SPECTROSCOPY; PROTEINS; PROTONS; SERINE ENDOPEPTIDASES; STEROID ISOMERASES; TRIOSE-PHOSPHATE ISOMERASE;

EID: 0033562690     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(19990515)35:3<275::AID-PROT1>3.0.CO;2-V     Document Type: Review

References (54)

1. Cleland WW, Frey PA, Gerlt JA. The low barrier hydrogen bond in enzymatic catalysis. J Biol Chem 1998;273:25529-25532.
2. Mildvan AS, Harris TK, Abeygunawardana C. NMR methods for the detection and study of low-barrier hydrogen bonds on enzymes. Methods Enzymol 1999;308; in press.
3. Hibbert F, Emsley J. Hydrogen bonding and chemical reactivity. Advances in Physical Organic Chem 1990;26:255-379.
4. 1. J Am Chem Soc 1980;102:3315-3322.
5. Steiner Th, Saenger W. Lengthening of the covalent O - H bond in O - H····O hydrogen bonds re-examined from low-temperature neutron diffraction data of organic compounds. Acta Crystallogr 1994;B50:348-357.
6. Donohue J. Structural chemistry and molecular biology. San Francisco: WH Freeman, 1968. p 443.
7. Adalsteinsson H, Maulitz AH, Bruice TC. Calculation of the potential energy surface for intermolecular amide hydrogen bonds using semiempirical and ab initio methods. J Am Chem Soc 1996;119:7689-7693.
8. Smallwood CJ, McAllister MA. Characterization of low-barrier hydrogen bonds. 7. Relationship between strength and geometry of short-strong hydrogen bonds. The formic acid-formate anion model system. An ab initio and DFT investigation. J Am Chem Soc 1997;119:11277-11281.
9. Shan S, Herschlag D. The change in hydrogen bond strength accompanying charge rearrangement: implications for enzymatic catalysis. Proc Natl Acad Sci USA 1996;93:14474-14479.
10. Makhatadze GI, Privalov P. Energetics of protein structure. Adv Protein Chem 1995;47:307-425.
11. Watson JD, Hopkins NH, Roberts JW, Steitz JA, Weiner AM. Molecular biology of the gene. Menlo Park, CA: Benjamin/ Cummings, 1987. p 132-138.
12. Warshel A, Papazyan A, Kollman PA. On low-barrier hydrogen bonds and enzyme catalysis. Science 1995;269:102-104.
13. Warshel A., Papazyan A. Energy considerations show that low-barrier hydrogen bonds do not offer a catalytic advantage over ordinary hydrogen bonds. Proc Natl Acad Sci USA 1996;93:13665-13670.
14. Guthrie JP. Short strong hydrogen bonds: can they explain enzymic catalysis? Chem Biol 1996;3:163-170.
15. Scheiner S, Kar T. The nonexistence of specially stabilized hydrogen bonds in enzymes. J Am Chem Soc 1995;117:6970-6975.
16. Cleland WW, Kreevoy MM. Low-barrier hydrogen bonds and enzymatic catalysis. Science 1994;264:1887-1890.
17. Robillard G, Shulman RG. High-resolution nuclear magnetic resonance studies of the active site of chymotrypsin. I. The hydrogen bonded protons of the "charge relay" system. J Mol Biol 1972;71:519-540.
18. 15N NMR spectra. Biochemistry (Moscow) 1994;59:613-624.
19. Frey PA, Whitt SA, Tobin JB. A low-barrier hydrogen bond in the catalytic triad of serine proteases. Science 1994;264:1927-1930.
20. Cassidy CS, Lin J, Frey PA. A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond. Biochemistry 1997;36:4576-4584.
21. Markley J, Ibanez IB. Zymogen activation in serine proteases: proton magnetic resonance pH titration studies of the two histidines of bovine chymotrypsinogen A and α-chymotrypsin. Biochemistry 1978;17:4637-4640.
22. Liang T-C, Abeles RH. Complex of α-chymotrypsin and N-acetyl-L-leucyl-L-phenylalanyltrifluoromethyl ketone: structural studies with NMR spectroscopy. Biochemistry 1987;26:7603-7608.
23. Markley JL, Westler WM. Protonation-state dependence of hydrogen bond strengths and exchange rates in a serine protease catalytic triad: bovine chymotrypsinogen A. Biochemistry 1996;35: 11092-11097.
24. Lin J, Westler WM, Cleland WW, Markley JL, Frey PA. Fractionation factors and activation energies for exchange of the low barrier hydrogen bonding proton in peptidyl trifluoromethyl ketone complexes of chymotrypsin. Proc Natl Acad Sci USA 1998;95: 14664-14668.
25. Kintanar A, Metzler CM, Metzler DE, Scott RD. NMR observation of exchangeable protons of pyridoxal phosphate and histidine residues in cytosolic aspartate aminotransferase. J Biol Chem 1991;266:17222-17229.
26. 15N heteronuclear multiple-quantum coherence NMR spectroscopy to study the active site of aspartate aminotransferase. Biochemistry 1997;36:615-625.
27. 5-3-ketosteroid isomerase. Proc Natl Acad Sci USA 1996;93:8220-8224.
28. 5-3-ketosteroid isomerase. Biochemistry 1997;36:14616-14626.
29. Harris TK, Abeygunawardana C, Mildvan AS. NMR studies of the role of hydrogen bonding in the mechanism of triosephosphate isomerase. Biochemistry 1997;36:14661-14675.
30. McDermott A, Ridenour CF. Proton chemical shift measurements in biological solids. In: Encyclopedia of NMR. Sussex, UK: Wiley, 1996:3820-3825.
31. 1H NMR chemical shifts in proteins. J Am Chem Soc 1983;105:5948-5949.
32. Schowen KB, Schowen RL. Solvent isotope effects on enzyme systems. Methods Enzymol 1982;87:551-606.
33. Kreevoy MM. The exposition of isotope effects on rates and equilibria. J Chem Educ 1964;41:636-638.
34. Loh SN, Markley JL. Hydrogen bonding in proteins as studied by amide hydrogen D/H fractionation factors: application to staphylococcal nuclease. Biochemistry 1994;33:1029-1036.
35. 15N labeled human ubiquitin by triple resonance NMR. J Am Chem Soc 1996;118:12864-12865.
36. LiWang AC, Bax A. Solution NMR characterization of hydrogen bonds in a protein by indirect measurement of deuterium quadrupole couplings. J Magn Reson 1997;127:54-64.
37. Davenport RC, Bash PA, Seaton BA, Karplus M, Petsko GA, Ringe D. Structure of the triosephosphate isomerase-phosphoglycolohydroxamate complex: an analogue of the intermediate on the reaction pathway. Biochemistry 1991;30:5821-5826.
38. Nickbarg EB, Davenport RC, Petsko GA, Knowles JR. Triosephosphate isomerase: removal of a putatively electrophilic histidine residue results in a subtle change in catalytic mechanism. Biochemistry 1988;27:5948-5960.
39. Harris TK, Cole RN, Comer FI, Mildvan AS. Proton transfer in the mechanism of triosephosphate isomerase. Biochemistry 1998;37: 16828-16838.
40. 5-3-ketosteroid isomerase complexed with the steroid 19-nortestosterone hemisuccinate Biochemistry 1998;37: 14701-14712.
41. 5-3-ketosteroid isomerase. Biochemistry 1989;28:149-159.
42. 5-3-ketosteroid isomerase by kinetic deuterium isotope effects. Biochemistry 1991;30:10858-10865.
43. 5-3-ketosteroid isomerase with and without a reaction intermediate analogue. Biochemistry 1997;36:14030-14036.
44. 5-3-ketosteroid isomerase reaction. Biochemistry 1990;29:10271-10280.
45. 5-3-ketosteroid isomerase in complexes with diamagnetic and paramagnetic steroids. Biochemistry 1997;36:3458-3472.
46. Kuhn P, Knapp M, Soltis SM, Granshaw G, Thoene M, Bott R. The 0.78 Å structure of a serine protease: Bacillus lentus subtilisin. Biochemistry 1998;37:13446-13452.
47. Carter P, Wells J. Dissecting the catalytic triad of a serine protease. Nature 1988;332:564-568.
48. Wang D, Bode W, Huber R J. Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8-Å resolution. J Mol Biol 1985;185:595-624.
49. Bao D, Kettner C, Huskey WP, Jordan F. Distinguished hydrogen bonding to active-site histidine in peptidyl boronic acid inhibitor complexes of chymotrypsin and subtilisin: proton magnetic resonance assignments and H/D fractionation. J Am Chem Soc 1999; in press.
50. Tsukada H, Blow DM. Structure of α-chymotrypsin refined at 1.68-Å resolution. J Mol Biol 1985;184:703-711.
51. Tulinsky A, Blevins RA. Structure of a tetrahedral transition state complex of α-chymotrypsin dimer at 1.8-Å resolution. J Biol Chem 1987;262:7737-7743.
52. Brady K, Wei A, Ringe D, Abeles RH. Structure of chymotrypsintrifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors. Biochemistry 1990;29:7600-7607.
53. Stoll VS, Eger BT, Hynes RC, Martichonok V, Jones JB, Pai EF. Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of γ-chymotrypsin and subtilisin carlsberg complexes. Biochemistry 1998; 37:451-462.
54. Nickbarg EB, Knowles JR. Triosephosphate isomerase: energetics of the reaction catalyzed by the yeast enzyme expressed in Escherichia coli. 1988;Biochemistry 27:5939-5947.